Related Experiment Video
Updated: Dec 25, 2025

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Transplanted senescent renal scattered tubular-like cells induce injury in the mouse kidney
Seo Rin Kim1,2, Kai Jiang1, Christopher M Ferguson1
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Abstract:
Cellular senescence, a permanent arrest of cell proliferation, is characterized by a senescence-associated secretory phenotype (SASP), which reinforces senescence and exerts noxious effects on adjacent cells. Recent studies have suggested that transplanting small numbers of senescent cells suffices to provoke tissue inflammation. We hypothesized that senescent cells can directly augment renal injury. Primary scattered tubular-like cells (STCs) acquired from pig kidneys were irradiated by 10 Gy of cesium radiation, and 3 wk later cells were characterized for levels of senescence and SASP markers. Control or senescent STCs were then prelabeled and injected (5 × 105 cells) into the aorta of C57BL/6J mice. Four weeks later, renal oxygenation was studied in vivo using 16.4-T magnetic resonance imaging and function by plasma creatinine level. Renal markers of SASP, fibrosis, and microvascular density were evaluated ex vivo. Per flow cytometry, irradiation induced senescence in 80-99% of STCs, which showed increased gene expression of senescence and SASP markers, senescence-associated β-galactosidase staining, and cytokine levels (especially IL-6) secreted in conditioned medium. Four weeks after injection, cells were detected engrafted in the mouse kidneys with no evidence for rejection. Plasma creatinine and renal tissue hypoxia increased in senescent compared with control cells. Senescent kidneys were more fibrotic, with fewer CD31+ endothelial cells, and showed upregulation of IL-6 gene expression. Therefore, exogenously delivered senescent renal STCs directly injure healthy mouse kidneys. Additional studies are needed to determine the role of endogenous cellular senescence in the pathogenesis of kidney injury and evaluate the utility of senolytic therapy.
Insights
Transplanted senescent renal cells directly cause kidney injury in mice. These senescent cells increased inflammation, fibrosis, and hypoxia, highlighting a potential role for cellular senescence in kidney disease.
Area of Science:
- Nephrology
- Cell Biology
- Immunology
Background:
- Cellular senescence, a state of irreversible cell cycle arrest, is marked by a senescence-associated secretory phenotype (SASP).
- The SASP contributes to tissue inflammation and can harm neighboring cells, with senescent cells potentially provoking tissue inflammation upon transplantation.
- The direct impact of senescent cells on renal injury remains to be fully elucidated.
Purpose of the Study:
- To investigate whether exogenously delivered senescent renal cells can directly augment kidney injury.
- To characterize the effects of transplanted senescent renal cells on renal function, oxygenation, fibrosis, and microvasculature in a mouse model.
Main Methods:
- Primary scattered tubular-like cells (STCs) from pig kidneys were induced into senescence via irradiation.
- Senescent and control STCs were injected into the aorta of C57BL/6J mice.
- Renal oxygenation, plasma creatinine, fibrosis, microvascular density, and SASP markers were assessed post-injection.
Main Results:
- Irradiation successfully induced senescence in STCs, characterized by increased SASP marker expression and IL-6 secretion.
- Engrafted senescent STCs led to increased plasma creatinine and renal tissue hypoxia in mice compared to controls.
- Senescent cell engraftment resulted in increased renal fibrosis and decreased microvascular density (CD31+ cells).
Conclusions:
- Exogenously delivered senescent renal cells directly induce injury in healthy mouse kidneys.
- The findings suggest a direct pathogenic role for senescent cells in kidney damage.
- Further research is warranted to explore endogenous cellular senescence in kidney injury and the efficacy of senolytic therapies.

